Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma

Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma

Chimeric antigen receptor T-cells (CAR-T) are now a standard approach for treating relapsed/refractory B-cell lymphomas. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) is a newly described entity that can manifest following CAR-T. Bone marrow (BM) aplasia i...

Full description

Bibliographic Details
Main Authors: Troy J. Kenkel, Nithya Sridhar, Lindsay R. Hammons, Maria Hintzke, Nirav N. Shah
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Medical Sciences
Subjects:
chimeric antigen receptor T-cell
Burkitt lymphoma
aplastic anemia
immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome
Online Access:https://www.mdpi.com/2076-3271/11/4/67

Internet

https://www.mdpi.com/2076-3271/11/4/67

Similar Items